non-COPD group needs explanation. Without getting a broncho-provocative challenge test, it is likely that a good number of subjects in non-COPD group might actually have asthma. The significant economic and healthcare burden of this non-COPD group is hence obvious and not surprising. 3 In view of diverse aetiologies in a non-COPD group, it is difficult to justify the use of the term 'exacerbation like events' for this varied patient group, and compare their symptom spurts with those of acute exacerbations of COPD.
These terminologies 'non-COPD patients' and 'exacerbation like event' should be used with caution, as it may, inadvertently, lead to the creation of a separate disease group, creating confusion about the correct terminology. Moreover, being easy to label, these terms are prone to be misused for all non-COPD patients, without subjecting them to detailed investigations.
It would be useful if authors exclude known causes of chronic symptoms in non-COPD patients before evaluating and comparing them with COPD. Proper diagnosis and categorisation of these non-COPD patients could help in proper management, as well as may change the course of their disease.
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